Table 3.
Constipation scoring system (CSS) subcategory scores in both groups at baseline and endpoint.
| DKTa group (N = 17) | Intragroup difference | Control group (N = 17) | Intragroup difference | Intergroup difference | |||
|---|---|---|---|---|---|---|---|
| Baseline | Endpointb | P* | Baseline | Endpoint | P | P | |
| Q1 (points) | 2.2 ± 1.5 | 1.2 ± 1.4 | <0.01 | 2.1 ± 1.4 | 2.1 ± 1.5 | 0.33 | <0.01 |
| Q2 (points) | 0.5 ± 0.9 | 0.3 ± 0.7 | — | 0.6 ± 0.9 | 0.6 ± 0.9 | — | 0.07 |
| Q3 (points) | 1.2 ± 1.2 | 0.8 ± 1.0 | 0.049 | 1.5 ± 1.3 | 1.6 ± 1.4 | 0.33 | 0.03 |
| Q4 (points) | 0.4 ± 0.8 | 0.4 ± 0.7 | — | 0.7 ± 0.9 | 0.7 ± 0.9 | — | 0.33 |
| Q5 (points) | — | — | — | — | — | — | — |
| Q6 (points) | 1.8 ± 0.5 | 1.4 ± 0.8 | 0.03 | 1.7 ± 0.7 | 1.7 ± 0.7 | 1.00 | 0.02 |
| Q7 (points) | 0.1 ± 0.2 | 0.1 ± 0.2 | — | 0.1 ± 0.2 | 0.1 ± 0.2 | — | 1.00 |
| Q8 (points) | 1.9 ± 1.1 | 1.9 ± 1.1 | — | 1.5 ± 0.9 | 1.5 ± 0.9 | — | 1.00 |
Intragroup difference was calculated using the paired t-test only when the intergroup difference was significant.
aDKT, Daikenchuto.
bEndpoint: after the 4-week trial period.
*Significance designated at P < 0.05.